Search research articles
Contact Us
Filters
Showing results (1-10 of 114) with videos related to
Page
of 12
Sort By:
Clinical Colorectal Cancer
|
April 10, 2010
A phase II trial of FOLFOX6 and cetuximab in the first-line treatment of patients with metastatic colorectal cancer
Ralph V Boccia, Thomas M Cosgriff, David L Headley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 22, 2013
Vandetanib plus chemotherapy for induction followed by vandetanib or placebo as maintenance for patients with advanced non-small-cell lung cancer: a randomized phase 2 PrECOG study (PrE0501)
Joseph Aisner, Judith B Manola, Shaker R Dakhil, et al.
American Journal of Clinical Oncology
|
March 23, 2011
Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical Trial
Steven Robert Alberts, Tom R Fitch, George P Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2012
Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base
Jeffrey J Kirshner, Charles E Heckler, Michelle C Janelsins, et al.
The Oncologist
|
March 14, 2022
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma
Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Targeted Oncology
|
November 10, 2025
Two Phase II Trials of Adavosertib, a Wee1 Inhibitor with Docetaxel or Carboplatin plus Pemetrexed in Non-small-cell Lung Cancer
Melissa L Johnson, Shaker R Dakhil, J Thaddeus Beck, et al.
Supportive Cancer Therapy
|
July 17, 2008
Decision-making role preferences of patients receiving adjuvant cancer treatment: a university of Rochester cancer center community clinical oncology program
Cleveland G Shields, Gary R Morrow, Jennifer Griggs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2012
Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy
Joseph A Roscoe, Charles E Heckler, Gary R Morrow, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 27, 2002
Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study
Robert P Whitehead, Danika Lew, Robert C Flanigan, et al.
Blood
|
August 15, 2002
Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase
Alan F List, Kenneth J Kopecky, Cheryl L Willman, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 114) with videos related to
Sort By:
Page
of 12
Clinical Colorectal Cancer
|
April 10, 2010
A phase II trial of FOLFOX6 and cetuximab in the first-line treatment of patients with metastatic colorectal cancer
Ralph V Boccia, Thomas M Cosgriff, David L Headley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 22, 2013
Vandetanib plus chemotherapy for induction followed by vandetanib or placebo as maintenance for patients with advanced non-small-cell lung cancer: a randomized phase 2 PrECOG study (PrE0501)
Joseph Aisner, Judith B Manola, Shaker R Dakhil, et al.
American Journal of Clinical Oncology
|
March 23, 2011
Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical Trial
Steven Robert Alberts, Tom R Fitch, George P Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2012
Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base
Jeffrey J Kirshner, Charles E Heckler, Michelle C Janelsins, et al.
The Oncologist
|
March 14, 2022
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma
Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
Targeted Oncology
|
November 10, 2025
Two Phase II Trials of Adavosertib, a Wee1 Inhibitor with Docetaxel or Carboplatin plus Pemetrexed in Non-small-cell Lung Cancer
Melissa L Johnson, Shaker R Dakhil, J Thaddeus Beck, et al.
Supportive Cancer Therapy
|
July 17, 2008
Decision-making role preferences of patients receiving adjuvant cancer treatment: a university of Rochester cancer center community clinical oncology program
Cleveland G Shields, Gary R Morrow, Jennifer Griggs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 2012
Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy
Joseph A Roscoe, Charles E Heckler, Gary R Morrow, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 27, 2002
Phase II trial of recombinant human interleukin-4 in patients with advanced renal cell carcinoma: a southwest oncology group study
Robert P Whitehead, Danika Lew, Robert C Flanigan, et al.
Blood
|
August 15, 2002
Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase
Alan F List, Kenneth J Kopecky, Cheryl L Willman, et al.
Page
of 12